This week, San Diego-based company Biolinq raked in $58 million in a funding round led by Alpha Wave Ventures, bringing its total funding to date to $178 million. The company, founded in 2012, is ...

The US Food and Drug Administration (FDA) has granted de novo classification to Biolinq Shine, a wearable biosensor that would be the first needle-free continuous glucose monitoring (CGM) device to ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. The Biolinq Shine is a needle-free CGM intended for use ...